Clinical implication of urinary midkine as a sensitive biomarker of acute kidney injury

尿中期因子作为急性肾损伤敏感生物标志物的临床意义

基本信息

  • 批准号:
    18390247
  • 负责人:
  • 金额:
    $ 10.57万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

Although acute kidney injury (AKI) is the most important predictor of the prognosis of the patients treated in the field of ICU, there have been no sensitive biomarkers to diagnose AKI before the rising of serum creatinine. Recently, several urinary biomarkers such as NGAL, IL-18, KIM-1, NHE3, KC, and L-FABP are reported as a candidate of new sensitive biomarker of AKI.We reported that midkine(MK), a heparin-binding growth factor, was induced in the diseased kidneys and promoted chemotaxis of leukocytes in the animal models of an ischemic renal reperfusion injury(Sato W., et. al., J Immunol 2001 ; 167 : 3463-3469). The enhanced expression of MK was detected mainly in the proximal tubules after ischemic injuries. Here, we evaluated whether human MK is shed into urine from the tubular epithelial cells, and may serve as a potent urinary biomarker of acute kidney injuries in human.Western blot analysis showed that the increased expression of MK was detected in the culture media from cultur … More ed human tubular epithelial(HK2)cells treated with hypoxia, but not from HK2 cells treated with 20 μM BSA. There were no differences in the MK expression in the cell lysates.For the measurement of urinary MK, 583 patients, including controls (n=33), patients with different forms of acute tubular necrosis (ATN) (n=33), and patients with other chronic renal diseases(n= 517), were studied. Urinary MK level was determined by enzyme-linked immunoassay.The urinary MK levels were significantly higher in patients with ATN compared to levels in patients with other chronic renal diseases or controls. For concentration in urine of MK, the receiver-operating characteristic(ROC)curve analysis for diagnosis of ATN showed that sensitivity was 97.0 %, and specificity was 91.1 % for a cut-off value of 70.0 pg/ml.We have confirmed that urinary MK level serves as a sensitive biomarker of ATN facilitating the early diagnosis of the disease. We obtained the patent(2008-048954, Ref : K20070222)for "Clinical examination for the early diagnosis of AKI : Urinary MK measurement". Less
尽管急性肾脏损伤(AKI)是ICU领域治疗的患者预后的最重要预测指标,但在血清创造兴起之前,没有敏感的生物标志物可以诊断AKI。 Recently, several urinary biomarkers such as NGAL, IL-18, KIM-1, NHE3, KC, and L-FABP are reported as a candidate of new sensitive biomarkers of AKI.We reported that midkine(MK), a heparin-binding growth factor, was induced in the disseased kidneys and promoted chemotaxis of leukocytes in the animal models of an ischemic renal reperfusion伤害(Sato W.等,J Immunol 2001; 167:3463-3469)。缺血性损伤后主要在近端管中检测到MK的增强表达。在这里,我们评估了人类MK是否从肾小管上皮细胞中脱落到尿液中,并且可以作为人类急性肾脏损伤的潜在尿生物标志物。西方印迹分析表明,在培养物中,MK在培养培养基中的表达增加了……从培养物中发现了更多的ED ED ED ED ED ED ED -ED -ED -ED -ED -ED -HUMANE EPITHELIAL(HK2)细胞(HK2),而不是用Hkke hkk ber hkk,而不是HKK 2。细胞裂解物中MK表达没有差异。对于尿液MK的测量,583例患者,包括对照组(n = 33),患有不同形式的急性结核性坏死(n = 33)的患者(n = 33),以及其他慢性肾疾病的患者(n = 517),是研究的。通过酶联免疫测定确定尿MK水平。与其他慢性肾脏疾病或对照组的患者相比,ATN患者的尿MK水平明显更高。对于MK尿液的浓度,用于诊断ATN的接收器操作特征(ROC)曲线分析表明,敏感性为97.0%,特异性为91.1%,截止值为70.0 pg/ml.我们已经确认,尿液MK水平是一种敏感的生物标志物,可以在早期诊断中诊断为早期诊断。我们获得了专利(2008-048954,参考:K20070222),用于“ AKI早期诊断的临床检查:尿液MK测量”。较少的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A protein toxin from the sea anemone Phyllodiscus semoni targets the kidney and causes a severe renal injury with predominant glomerular endothelial damage
  • DOI:
    10.2353/ajpath.2007.060984
  • 发表时间:
    2007-08-01
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Mizuno, Masashi;Nozaki, Masatoshi;Matsuo, Seiichi
  • 通讯作者:
    Matsuo, Seiichi
High levels of complement C3a receptor in the glomeruli in lupus nephritis
  • DOI:
    10.1053/j.ajkd.2007.02.271
  • 发表时间:
    2007-05-01
  • 期刊:
  • 影响因子:
    13.2
  • 作者:
    Mizuno, Masashi;Blanchin, Stephanie;Matsuo, Seiichi
  • 通讯作者:
    Matsuo, Seiichi
Effects of olprinone, a phosphodiesterase III inhibitor, on ischemic acute renal failure
  • DOI:
    10.1111/j.1442-2042.2007.01689.x
  • 发表时间:
    2007-03-01
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Anas, Chabouk;Ozaki, Takenori;Matsuo, Seiichi
  • 通讯作者:
    Matsuo, Seiichi
Diabetic nephropathy in transgenic mice overexpressing beta cell cahnodulin
过度表达β细胞钙调蛋白的转基因小鼠的糖尿病肾病
Impact of Renal Dysfunction on Uptake of F-18 Fluorodeoxylucose on Positron Emission Tomography in Arterial Plaques
肾功能障碍对动脉斑块正电子发射断层扫描中 F-18 氟脱氧葡萄糖摄取的影响
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hirotake;Kasuga
  • 通讯作者:
    Kasuga
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUO Seiichi其他文献

MATSUO Seiichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUO Seiichi', 18)}}的其他基金

Development of novel therapy for kidney injury by leukocyte targeting antibody-fused Bionanocapsules
开发白细胞靶向抗体融合生物纳米胶囊治疗肾损伤的新疗法
  • 批准号:
    25670408
  • 财政年份:
    2013
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Elucidation of molecular mechanisms involved in the immunomodulatory function of newly developed adipose tissue derived mesenchymal stem cells
阐明新开发的脂肪组织来源的间充质干细胞的免疫调节功能的分子机制
  • 批准号:
    23659443
  • 财政年份:
    2011
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
International comparison of genomic variations for prognostic factors in chronic kidney disease
慢性肾脏病预后因素基因组变异的国际比较
  • 批准号:
    23406027
  • 财政年份:
    2011
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Epidemiological analysis on chronic kidney disease in Asian population after standardization of creatinine measurement
肌酐测量标准化后亚洲人群慢性肾脏病的流行病学分析
  • 批准号:
    20406022
  • 财政年份:
    2008
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Asian Collaborative Study for Creation of GFR Estimation Equation (ACOS-CG-FREE)
创建 GFR 估计方程的亚洲合作研究 (ACOS-CG-FREE)
  • 批准号:
    18406032
  • 财政年份:
    2006
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic research for the development of new therapeutic measures against progressive tubuloinetsrtitial injury.
开发针对进行性肾小管损伤的新治疗措施的基础研究。
  • 批准号:
    15390269
  • 财政年份:
    2003
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Research on The Role of Proximal Tubular Cells in The Development of Tubulointerstitinal Injury.
近端肾小管细胞在肾小管间质损伤发展中作用的研究。
  • 批准号:
    13671110
  • 财政年份:
    2001
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel therapeutic approach to the renal injury by the control of anaphylatoxins.
通过控制过敏毒素开发一种新的肾损伤治疗方法。
  • 批准号:
    13557085
  • 财政年份:
    2001
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Role of Anaphylatoxins, C3a, C5a, in Renal Injury.
过敏毒素、C3a、C5a 在肾损伤中的作用。
  • 批准号:
    11671033
  • 财政年份:
    1999
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research on The Mechanisms of Tubulointerstitial Injury by Proteinuria.
蛋白尿损伤肾小管间质的机制研究。
  • 批准号:
    09671160
  • 财政年份:
    1997
  • 资助金额:
    $ 10.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

基于Bacillus subtilis 细胞传感器介导的肠道环境中结直肠癌相关生物标志物的动态检测策略
  • 批准号:
    82372355
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
“微生物-肠-脑轴”调节抑郁症睡眠障碍的机制及其作为rTMS治疗效果预测的生物标志物研究
  • 批准号:
    82371928
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于肝癌多组学数据集成的肝癌生物标志物智能解析与预测方法研究
  • 批准号:
    62333018
  • 批准年份:
    2023
  • 资助金额:
    237 万元
  • 项目类别:
    重点项目
长牡蛎体内砷形态转化的剂量-效应关系、发生机制及生物标志物研究
  • 批准号:
    42306158
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于多源异构数据融合与知识补全策略的证候生物标志物知识图谱构建方法研究
  • 批准号:
    82305439
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Developmental Origins of Kidney Function in Early Life and Environmental Risks
生命早期肾功能的发育起源和环境风险
  • 批准号:
    10445341
  • 财政年份:
    2020
  • 资助金额:
    $ 10.57万
  • 项目类别:
Developmental Origins of Kidney Function in Early Life and Environmental Risks
生命早期肾功能的发育起源和环境风险
  • 批准号:
    10064557
  • 财政年份:
    2020
  • 资助金额:
    $ 10.57万
  • 项目类别:
Kidney Tubular Functions in Type 1 Diabetes
1 型糖尿病的肾小管功能
  • 批准号:
    10449358
  • 财政年份:
    2020
  • 资助金额:
    $ 10.57万
  • 项目类别:
Kidney Tubular Functions in Type 1 Diabetes
1 型糖尿病的肾小管功能
  • 批准号:
    10264925
  • 财政年份:
    2020
  • 资助金额:
    $ 10.57万
  • 项目类别:
Developmental Origins of Kidney Function in Early Life and Environmental Risks
生命早期肾功能的发育起源和环境风险
  • 批准号:
    10659018
  • 财政年份:
    2020
  • 资助金额:
    $ 10.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了